TISA-818-Inj

· EnliTISA (Shanghai) Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TISA-818-Inj, covering 2026-01-13 to 2026-01-13. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Safety, Tolerability, and Pharmacokinetics in Healthy Adult Subjects After Subcutaneous Injection of TISA-818-Inj [Phase 1]

See pricing